The US product labeling describes Ultracet as tramadol plus acetaminophen and highlights risks of opioid misuse, respiratory depression, liver toxicity, and sedative interactions in the
FDA prescribing information. A 2025 systematic review also found that tramadol, with or without acetaminophen, has meaningful harms that must be weighed against its pain benefit (
review, PMID 40940161).